Atlas Trials

Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.

Clinical trial NCT02072057 · TERMINATED

Trial details

NCT number
NCT02072057
Sponsor
Kantonsspital Aarau
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer Cachexia
Start date
2014-04-20
Primary completion
2018-11-30
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.